High Ki-67 values in patients with breast cancer can correlate with attainment of complete pathological response and can be inculcated in the initial clinical assessment of the breast cancer patients to predict the effectiveness of response to chemotherapy and prevent unnecessary side effects in patients who would not respond to chemotherapy. The gene discussed is MKI67; the disease is breast cancer.